Vanguard Group’s Lixte Biotechnology LIXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$244K Buy
2023
Q2
Sell
2023
Q1
$27.1K Sell
2022
Q4
$41.3K Hold
2022
Q3
$45K Sell
2022
Q2
$62K Hold
2022
Q1
$103K Buy
2021
Q4
$92K Sell
2021
Q3
$162K Buy
2021
Q2
$225K Buy